Hepsiburada Announces Second Quarter 2026 Financial Results
HEPS likely to remain volatile short-term on IAS 29 restatement; profitability path hinges on GMV/margin stabilization over the next 6–12 months.
Signal detail
Source-backed analysis, the reasoning behind the signal, and its market context.
HEPS likely to remain volatile short-term on IAS 29 restatement; profitability path hinges on GMV/margin stabilization over the next 6–12 months.
What happened and why it matters
Hepsiburada reported Q2 2026 results restated under IAS 29, reflecting Turkish hyperinflation adjustments. Revenue rose 3.1% to 22,810.9 million TRY, with GMV up 2.8% to 56.7 billion, yet net loss widened to 1,889.6 million TRY as growth investments and higher marketing costs weighed on margins. The catalyst is IAS 29 restatement and ongoing growth initiatives, including the Hepsitaksit fintech launch, shaping profitability trajectory in H2 2026.
Inflation-restatement introduces non-cash reallocation of historical numbers, which may confuse near-term earnings interpretation. While revenue and GMV show growth, the widened net loss and weaker EBITDA margin could pressure the stock temporarily. The Kaspi.kz stake and fintech expansion present optionality, but immediate price moves will likely hinge on margin stabilization and progress of growth initiatives.
IAS 29 restatement applied; June 30, 2026 results restated.
Q2 2026 revenue up 3.1% to 22,810.9 TRY; GMV up 2.8% to 56.7B.
Net loss Q2 2026: 1,889.6 million; EBITDA 239.2 million; 0.4% GMV.
Free cash flow fell 65.5% to 1,553.2 million TRY in Q2.
Hepsiburada launches Hepsitaksit; fintech contribution 0.4% of GMV in first month.
Category: Earnings. The release centers on restated IFRS results under IAS 29 and quarterly earnings, signaling how inflation adjustments affect reported profitability and capital allocation; important for evaluating HEPS's earnings quality and growth runway.
More AI-analyzed coverage connected to this story